Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer. - Herzog SK; Stevens JH; Gu G; Grimm SL; Cardoza K; Hawkins AGM; Lin H; Ramos D; Beyer AR; Edwards DG; Dustin D; Yang HJ; et al. (Cancer research, 2026)